https://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencySun, 16 Jun 2024 12:13:21 +0200Wed, 31 Jan 2024 11:30:00 +0100https://www.ema.europa.eu/en/medicines/human/EPAR/rimmyrahHuman medicines European public assessment report (EPAR): Rimmyrah, ranibizumab, Date of authorisation: 05/01/2024, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/rimmyrahWed, 31 Jan 2024 11:30:00 +0100Human medicinehttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-6055-en.pdfRimmyrah : EPAR - Product informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-6055-en.pdfWed, 31 Jan 2024 11:08:23 +0100Human medicine